44PCorrelation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial. (16th September 2018) - Tredan, O; Zelichov, O; Barbash, Z; Daitsh, Y; Birnbaum, L; Tarcic, G; You, B; Cassier, P; de la Fouchardiere, C; Ray-Coquard, I L; Brahmi, M; Wang, Q; et al.